Skip to main content
DYN logo

DYN · Dyne Therapeutics, Inc. · Executive Compensation

Track DYN — free
$15.50 -0.53 (-3.31%) At close · Nov 20
Market Cap
$2.90B
Shares
187.39M
Volume · Nov 20 2.23M Avg daily vol (3M) 2.91M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Erick Lucera $2,695,986
John G. Cox $2,076,868
Johanna Friedl-Naderer $1,086,420
Douglas Kerr $1,057,598
Oxana Beskrovnaya $992,628
Richard Scalzo $727,638
Fiscal 2024
Executive Total
John G. Cox $20,688,724
Josh Brumm $14,383,011
Johanna Friedl-Naderer $8,190,480
Douglas Kerr $7,741,647
Oxana Beskrovnaya $3,835,650
Richard Scalzo $2,485,672
Fiscal 2023
Executive Total
Josh Brumm $5,974,491
Jonathan McNeill $2,230,830
Susanna High $2,045,442
Oxana Beskrovnaya $1,997,845
Fiscal 2022
Executive Total
Josh Brumm $4,317,103
Susanna High $1,594,292
Oxana Beskrovnaya $1,486,373
Fiscal 2021
Executive Total
Joshua Brumm $4,086,611
Oxana Beskrovnaya $2,908,952
Susanna High $1,690,621
Fiscal 2020
Executive Total
Joshua Brumm $11,868,105
Romesh Subramanian $4,370,975
Susanna High $3,745,915
Fiscal 2019
Executive Total
Romesh Subramanian $411,660
Joshua Brumm $277,314

Executive changes

Person Change Filed
Barry E. Greene Appointed 2026-06-22
Vikram Karnani Appointed 2025-12-23
Brian Posner Appointed 2025-10-02
Erick Lucera Appointed 2025-03-20
Johanna Friedl-Naderer Appointed 2024-09-03
Doug Kerr Appointed 2024-09-03
Lucia Celona Appointed 2024-09-03
Wildon Farwell Resigned 2024-09-03
Susanna High Resigned 2024-09-03
Jonathan McNeill, M.D. Resigned 2024-09-03
Joshua Brumm Resigned 2024-03-25
Joshua Brumm Resigned 2024-03-25
John Cox Appointed 2024-03-25
John Cox Appointed 2024-03-25
Dr. Lawrence Klein
“Dr. Klein informed the Company that his resignation was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2023-05-25
Oxana Beskrovnaya Ph.D. Appointed 2021-06-02
Romesh Subramanian Resigned 2021-06-02

Leadership

Key facts CIK 1818794 CUSIP 26818M108 13F (30d) 281 filings 255 filers Visit website Investor relations